LLY
ELI LILLY & CO
Health Care·Pharmaceuticals·UNITED STATES
$1,144.68
MCap $1T
as of 2026-06-09
Total
A1w
Fund
B1w
Quant
A1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-10
MIDOS SI
-0.35
Sentiment 77.3%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$1,144.68
Adaptive Mean
$1,153.01
-8.33 vs mean
Adaptive σ
11.76
MIDOS BB
$1,129.49 – $1,176.53
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
+0.45
ROE
107.6%
Z +2.07
Rev Gr
55.5%
Z +0.17
EPS Gr
95.6%
Z +0.29
OPM Gr
55.1%
Z +0.02
FCF Yld
1.3%
Z +0.15
EPS Surp
25.1%
Z +0.15
EPS 3mo Δ
8.2%
Z +0.26
Fwd P/E
25.73
Z —
PEGY
0.17
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-06-10
Q3M
4.62
Q6M
3.07
Q12M
4.71
MA 30/100
1.031
Bullish (MA30 > MA100)
α (Jensen)
0.3362
β (12M)
0.53
σ (12M)
0.381
Divergence — Fundamentals vs Momentum
Z Percentile
91%
Q Percentile
80%
Divergence
+11.2
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
1.6
RS Pctl
54%
RS Decile
D6
Persistence
1w
at grade A
Options / OI Analysis
No options or Williams data available for this ticker.